GW Pharmaceuticals plc's cannabis-based drug for epilepsy, Epidiolex, won the unanimous backing of an advisory panel to the FDA on April 19, 2018. The FDA's final decision on Epidiolex is expected by June 27, 2018. If approved, Epidiolex would be the first-ever medicine derived from a marijuana plant to be greenlighted by the FDA.
-Advanced Biomedical Technologies Inc., a developer and manufacturer of orthopaedic internal fixation devices, announced today that it has received approval from the China Food and Drug Administration for its polymer orthopaedic internal fixation screws. Company CEO Ms Hui Wang said, Today is a momentous day for our company and biomaterial technolo
Unless the context otherwise requires, all references to "we", "us", the "Company", or "NeuroMetrix" in this Quarterly Report on Form 10- Q refer to NeuroMetrix, Inc.. NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, slee
-via OTC PR WIRE Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter pain management market, announced today that they have partnered with NxGen Brands, LLC; a company specializing in the sales and marketing of innovative healthcare products and service solutions, to market and distribute
Procter& Gamble Co. will buy a majority stake in Merck Ltd, the Indian publicly traded unit of the German drug maker, for Rs1, 289.88 crore, as part of a global transaction to acquire Merck KGaAs international consumer health business for $4.2 billion. P&G will acquire a 51.8% stake in Merck Ltd, a move that will require the American consumer goods
Sunovion Pharmaceuticals Inc. today announced that Health Canada has approved the Supplemental New Drug Submission that expands the use of Latuda to include the acute management of depressive episodes associated with bipolar I disorder in adolescents. LATUDA is currently indicated in Canada for the management of the manifestations of...
The "The U.S. Sleep Market 2018: Competitive& Operating Analysis" report has been added to ResearchAndMarkets.com' s offering. All of this has become a $28.6 billion a year industry. First launched in 1977, there are now an estimated 4,700 sleep labs or centers in the United States.
The "The U.S. Sleep Market 2018: Competitive& Operating Analysis" report has been added to ResearchAndMarkets.com' s offering.. All of this has become a $28.6 billion a year industry. As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. First launched in 1977, there are
Advanced Biomedical Technologies Inc., a developer and manufacturer of orthopaedic internal fixation devices, announced today that it has received approval from the China Food and Drug Administration for its polymer orthopaedic internal fixation screws. Company CEO Ms Hui Wang said, Today is a momentous day for our company and biomaterial tech
Monday evenings at 63 Jefferson Ave., Salem; and from noon to 1:30 p.m. Fridays at 75 Lindall St., Danvers. The Beverly and Addison Gilbert Hospital's Speakers Bureau is a free service designed to bring timely information on a variety of health-related topics. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors' conference room at
via OTC PR WIRE Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, announced today that they have partnered with NxGen Brands, LLC; a company specializing in the sales and marketing of innovative healthcare products and service solutions, to market and dist
Teva Pharmaceutical Industries has announced that Teva and the Procter& Gamble Company have agreed to terminate the PGT Healthcare partnership that the two companies established in 2011 to market OTC medicines. PGT Healthcare has grown into a significant presence in over 50 countries, mainly in Europe and Asia, using market-leading brands such as V
In Raleigh on Tuesday afternoon to meet with law enforcement and federal prosecutors in North Carolina, Sessions laid out some of the ideas the Trump administration has for battling a crisis with opioids that he said left 64,000 dead in this country in 2016.. Sessions, a former Republican senator from Alabama who rolled back many of the Justice Dep
"Cost has for many years been the number one problem," Barbara Kelley, executive director and CEO of the Hearing Loss Association of America told Kaiser. Last year Congress passed a law allowing the Food and Drug Administration to authorize over-the-counter hearing aids for people with mild to moderate hearing loss. A a new bipartisan Senate bill,
Eloxx Pharmaceuticals, Inc.,, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that two abstracts, including one Later Breaker, for its lead...
"While it's been nearly one year since the FDA approved a second treatment option for ALS, there is still much to learn about this devastating disease," said Jean Hubble, M.D., Vice President of Medical Affairs, MTPA. Big Data Analytics for Early Diagnosis of Amyotrophic Lateral Sclerosis Abstract 459, Poster Session P4, Wednesday, April 25 from 11
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that two large Northeast regional health plans have placed ARYMO ER extended-release tablets for oral use only CII in a preferred formulary position..
PUNE, INDIA, April 17, 2018/ EINPresswire.com/ WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report Global Point of Care Testing Devices Outlook 2024. The global point of care testing diagnostics market is estimated to reach USD 20 billion by the year 2024.. Cholestech In
Halo Pharma will be discussing its capabilities in topical drug products at CPhI NA, Booth 1549, at the Pennsylvania Convention Center, April 24-26. Topical drug products, which Research and Markets predicts will reach global sales of $194.2 billion by 2024, target localized skin sites or offer systemic penetration by formulations that are easily a
Pune, India 04/17/2018 Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson& Johnson, Alere Inc., Instrumentation Laborato
By a News Reporter-Staff News Editor at Pharma Business Week Acerus Pharmaceuticals Corporation announced that is has been selected to present at the annual CHINABIO Partnering Forum 2018 to be held in Suzhou, China, on April 25 and 26, 2018. Acerus has already partnered NATESTO , a testosterone nasal gel for testosterone replacement therapy
HAYS- The Ellis County Drug Enforcement Unit will operate two collection sites from 10 a.m. to 2 p.m. April 28 during the Drug Enforcement Agency's Take Back Prescription Drug Day. Uniformed officers will be at Good Samaritan Center, 2700 Canal, and Hays Convention and Visitors Bureau, 2700 Vine, both in Hays. Kansas Wesleyan University will host t
PUNE, INDIA, April 16, 2018/ EINPresswire.com/ WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging. The primary objective of this report is to provide in-depth knowledge of the global pharma
The Basel, Switzerland- based biotech company Cinclus Pharma AG today announced that it has successfully completed the first clinical Phase 1 study of its lead compound X842, for the treatment of severe erosive Gastroesophageal reflux disease. In the US and Europe, 20-40% of adult population suffer from reflux disease. The acid reflux market- worth
Imagine turning back the clock on your achy joints and muscles. An all natural supplement by Optimum Life Labs called Joint Nirvana is now available in Ohio and people are calling it "the" joint and muscle pain "vaccine" Big Pharma doesn't want you to know about. "I've tried every pain pill the doctor has ever prescribed me and Joint Nirvana is th